9,101.43
+24.72
+(0.27%)
At close: 9:16:27 AM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 25 | 10 | 31 | 32 |
| Avg. Estimate | 2.78B | 2.79B | 10.88B | 11.8B |
| Low Estimate | 2.72B | 2.68B | 10.63B | 11.24B |
| High Estimate | 2.85B | 2.99B | 10.96B | 12.5B |
| Year Ago Sales | 2.52B | 2.69B | 9.87B | 10.88B |
| Sales Growth (year/est) | 10.60% | 3.87% | 10.26% | 8.46% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VRTX.MX | -- | -- | -- | -- |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Upgrades & Downgrades
| Downgrade | Wells Fargo: Overweight to Equal-Weight | 1/30/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 1/27/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/24/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 1/10/2025 |
| Maintains | Truist Securities: Buy to Buy | 12/23/2024 |
| Maintains | Scotiabank: Sector Perform to Sector Perform | 12/23/2024 |
Related Tickers
F6T.MU Fate Therapeutics Inc
1.2810
0.00%
GYX.F Futura Medical plc
0.3500
+1.74%
1BT.F Enlivex Therapeutics Ltd.
1.0500
-1.87%
1GDA.F Zevra Therapeutics, Inc.
7.45
0.00%
CVAC.VI CureVac N.V.
3.7580
-0.63%
HQ1.MU Oruka Therapeutics Inc. R
11.40
+1.79%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4620
-1.70%
ASCLF Ascletis Pharma Inc.
0.2393
0.00%
PI3.DU Gubra AS
88.60
-2.42%
471A.F aTyr Pharma, Inc.
3.4600
+5.49%